Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07235293 |
| Consolidated Lead Sponsor | Kahr Bio Australia Pty |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 90 participants (ESTIMATED) |
| Registered Start Date | 2026-01-16 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora, CO | Open Hospital Dossier -> |
| Duke University Medical Center | Durham, NC | Open Hospital Dossier -> |
| UPMC Hillman Cancer Center | Pittsburgh, PA | Open Hospital Dossier -> |
| Chris O'Brien Lifehouse | Camperdown, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.